SYRA
Syra Health Corp. Class A Common Stock
NASDAQ · Healthcare · Medical - Care Facilities · US
$0.93
+0.98%Year over year
Reported trailing growth
- Revenue
- +0.3%
- EBITDA
- +110.5%
- EBIT
- +105.1%
- EPS
- +104.6%
- Free cash flow
- +120.2%
- Operating cash flow
- +120.2%
Forward estimates
Based on analyst estimates
- Revenue
- -6.2%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +8.8%
- EBITDA
- +76.6%
- EBIT
- +76.0%
- Net income
- +76.2%
- EPS
- +85.5%
- Free cash flow
- +84.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026